Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity
Clinical trial NCT00772954 · TERMINATED
Trial details
- NCT number
- NCT00772954
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2006-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.